Physiomics to present on Personalized Medicine and Virtual Tumour at AACR 2021 Annual Meeting
Physiomics to present on Personalized Medicine and Virtual Tumour at AACR 2021 Annual Meeting
Physiomics to present on dual immuno-therapy at AACR 2020 Virtual Meeting II
London, UK , 16 June 2020: ValiRx (AIM:VAL) is pleased to provide the following corporate update.
Plans to Develop Etigilimab (Anti-TIGIT) Alongside Rare Disease Product Portfolio